EUVIMEDEUVIMED entdecken
Crossref

Recurrent Diarrhea Induced by Immune Checkpoint Inhibitor Therapy: Importance of Endoscopic Evaluation to Identify Causes Other Than Acute Immune-Related Colitis

Silpa Mandava, Deidre Rynerson, Nicole Eng, Raima A. Memon, Sehrish Jamot, Grace K. Dy

Annals of Internal Medicine: Clinical Cases · 01.06.2026 · 5 (6)

DOI: 10.7326/aimcc.2025.0551 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Internal Medicine: Clinical Cases, erschienen am 01.06.2026. Verfasst von Silpa Mandava und 5 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Mandava, S., Rynerson, D., Eng, N., Memon, R. A., Jamot, S., & Dy, G. K. (2026). Recurrent Diarrhea Induced by Immune Checkpoint Inhibitor Therapy: Importance of Endoscopic Evaluation to Identify Causes Other Than Acute Immune-Related Colitis. Annals of Internal Medicine: Clinical Cases, 5(6). https://doi.org/10.7326/aimcc.2025.0551

Vancouver

Mandava S, Rynerson D, Eng N, Memon RA, Jamot S, Dy GK. Recurrent Diarrhea Induced by Immune Checkpoint Inhibitor Therapy: Importance of Endoscopic Evaluation to Identify Causes Other Than Acute Immune-Related Colitis. Annals of Internal Medicine: Clinical Cases. 2026;5(6). doi:10.7326/aimcc.2025.0551

BibTeX
@article{Mandava2026,
  author = {Mandava, Silpa and Rynerson, Deidre and Eng, Nicole and Memon, Raima A. and Jamot, Sehrish and Dy, Grace K.},
  title = {Recurrent Diarrhea Induced by Immune Checkpoint Inhibitor Therapy: Importance of Endoscopic Evaluation to Identify Causes Other Than Acute Immune-Related Colitis},
  journal = {Annals of Internal Medicine: Clinical Cases},
  year = {2026},
  volume = {5},
  number = {6},
  doi = {10.7326/aimcc.2025.0551}
}
Kostenlos starten →